These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 28984400)

  • 21. Mutations of the KRAS oncogene in endometrial hyperplasia and carcinoma.
    Dobrzycka B; Terlikowski SJ; Mazurek A; Kowalczuk O; Niklińska W; Chyczewski L; Kulikowski M
    Folia Histochem Cytobiol; 2009; 47(1):65-8. PubMed ID: 19419940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonal Expansion and Diversification of Cancer-Associated Mutations in Endometriosis and Normal Endometrium.
    Suda K; Nakaoka H; Yoshihara K; Ishiguro T; Tamura R; Mori Y; Yamawaki K; Adachi S; Takahashi T; Kase H; Tanaka K; Yamamoto T; Motoyama T; Inoue I; Enomoto T
    Cell Rep; 2018 Aug; 24(7):1777-1789. PubMed ID: 30110635
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequent PIK3CA mutation in normal endometrial gland drives spheroid formation and may be involved in stem cell propagation.
    Sato S; Nakayama K; Kanno K; Sultana R; Ishikawa M; Ishibashi T; Yamashita H; Kyo S
    Cancer Sci; 2023 Jun; 114(6):2335-2344. PubMed ID: 36843384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microsatellite instability, MLH1 promoter methylation, and loss of mismatch repair in endometrial cancer and concomitant atypical hyperplasia.
    Horowitz N; Pinto K; Mutch DG; Herzog TJ; Rader JS; Gibb R; Bocker-Edmonston T; Goodfellow PJ
    Gynecol Oncol; 2002 Jul; 86(1):62-8. PubMed ID: 12079302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutual exclusiveness between PIK3CA and KRAS mutations in endometrial carcinoma.
    Kang S; Seo SS; Chang HJ; Yoo CW; Park SY; Dong SM
    Int J Gynecol Cancer; 2008; 18(6):1339-43. PubMed ID: 18221484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant expression of the von Hippel-Lindau gene in human endometrial hyperplasia and endometrial carcinoma.
    Xu JY; Zhu WJ; Cao XZ; Li XF; Wu J
    Int J Gynecol Cancer; 2011 Apr; 21(3):430-4. PubMed ID: 21436690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequent CTNNB1 or PIK3CA Mutations Occurred in Endometrial Endometrioid Adenocarcinoma With High Levels of Microsatellite Instability and Loss of MSH2/MSH6 Expression.
    Huang HN; Kuo CW; Lin MC; Mao TL; Kuo KT
    Appl Immunohistochem Mol Morphol; 2020 Apr; 28(4):284-289. PubMed ID: 30789355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients.
    de Leeuw WJ; Dierssen J; Vasen HF; Wijnen JT; Kenter GG; Meijers-Heijboer H; Brocker-Vriends A; Stormorken A; Moller P; Menko F; Cornelisse CJ; Morreau H
    J Pathol; 2000 Nov; 192(3):328-35. PubMed ID: 11054716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between PTEN expression and PI3K/Akt signal pathway in endometrial carcinoma.
    Gao Q; Ye F; Xia X; Xing H; Lu Y; Zhou J; Ma D
    J Huazhong Univ Sci Technolog Med Sci; 2009 Feb; 29(1):59-63. PubMed ID: 19224164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
    Sutter C; Dallenbach-Hellweg G; Schmidt D; Baehring J; Bielau S; von Knebel Doeberitz M; Gebert J
    Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endometrial tumorigenesis in Pten(+/-) mice is independent of coexistence of estrogen and estrogen receptor α.
    Joshi A; Wang H; Jiang G; Douglas W; Chan JS; Korach KS; Ellenson LH
    Am J Pathol; 2012 Jun; 180(6):2536-47. PubMed ID: 22503752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of K-ras mutations in cancerous lesions of human endometrium.
    Semczuk A; Berbéc H; Kostuch M; Kotarski J; Wojcierowski J
    Eur J Gynaecol Oncol; 1997; 18(1):80-3. PubMed ID: 9061333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activated mutant p110α causes endometrial carcinoma in the setting of biallelic Pten deletion.
    Joshi A; Miller C; Baker SJ; Ellenson LH
    Am J Pathol; 2015 Apr; 185(4):1104-13. PubMed ID: 25698082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laser-captured microdissection-microarray analysis of the genes involved in endometrial carcinogenesis: stepwise up-regulation of lipocalin2 expression in normal and neoplastic endometria and its functional relevance.
    Miyamoto T; Kashima H; Suzuki A; Kikuchi N; Konishi I; Seki N; Shiozawa T
    Hum Pathol; 2011 Sep; 42(9):1265-74. PubMed ID: 21334721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular pathogenesis of endometrial cancers in patients with Lynch syndrome.
    Huang M; Djordjevic B; Yates MS; Urbauer D; Sun C; Burzawa J; Daniels M; Westin SN; Broaddus R; Lu K
    Cancer; 2013 Aug; 119(16):3027-33. PubMed ID: 23760948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of the retinoblastoma-related gene Rb2/p130 is downregulated in atypical endometrial hyperplasia and adenocarcinoma.
    Susini T; Massi D; Paglierani M; Masciullo V; Scambia G; Giordano A; Amunni G; Massi G; Taddei GL
    Hum Pathol; 2001 Apr; 32(4):360-7. PubMed ID: 11331952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging relationships between papillary proliferation of the endometrium and endometrial carcinoma: evidence from an immunohistochemical and molecular analysis.
    Liu Q; Wu Q; Yu M; Shi H; Lu B
    Virchows Arch; 2019 Aug; 475(2):201-209. PubMed ID: 31079233
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A unique spectrum of somatic PIK3CA (p110alpha) mutations within primary endometrial carcinomas.
    Rudd ML; Price JC; Fogoros S; Godwin AK; Sgroi DC; Merino MJ; Bell DW
    Clin Cancer Res; 2011 Mar; 17(6):1331-40. PubMed ID: 21266528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The FOXA2 transcription factor is frequently somatically mutated in uterine carcinosarcomas and carcinomas.
    Le Gallo M; Rudd ML; Urick ME; Hansen NF; ; Merino MJ; Mutch DG; Goodfellow PJ; Mullikin JC; Bell DW
    Cancer; 2018 Jan; 124(1):65-73. PubMed ID: 28940304
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the quality and frequency of mutations occurrence in PTEN gene in endometrial carcinomas and hyperplasias.
    Konopka B; Paszko Z; Janiec-Jankowska A; Goluda M
    Cancer Lett; 2002 Apr; 178(1):43-51. PubMed ID: 11849740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.